Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120499492 | 12049949 | 2 | F | 2006 | 20160803 | 20160208 | 20160809 | EXP | US-ASTRAZENECA-2012SE74543 | ASTRAZENECA | 65.00 | YR | F | Y | 87.50000 | KG | 20160810 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120499492 | 12049949 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 10 | MG | TABLET | QD | |||||
| 120499492 | 12049949 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 10 | MG | TABLET | QD | |||||
| 120499492 | 12049949 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 10 | MG | TABLET | QD | |||||
| 120499492 | 12049949 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 120499492 | 12049949 | 5 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 0 | 400 | IU | CAPSULE | Q8H | |||||||
| 120499492 | 12049949 | 6 | C | ARIMIDEX | ANASTROZOLE | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
| 120499492 | 12049949 | 7 | C | OSCAL | CALCIUM CARBONATE | 1 | 0 | 500 | MG | TABLET | BID | ||||||||
| 120499492 | 12049949 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | 20 | MG | TABLET | QD | ||||||||
| 120499492 | 12049949 | 9 | C | BONIVA | IBANDRONATE SODIUM | 1 | 0 | 150 | MG | TABLET | /month | ||||||||
| 120499492 | 12049949 | 10 | C | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | 0 | ||||||||||||
| 120499492 | 12049949 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 6.25 | MG | TABLET | BID | |||||||
| 120499492 | 12049949 | 12 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 100 | MG | TABLET | QD | |||||||
| 120499492 | 12049949 | 13 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 0 | 1000 | MG | CAPSULE | BID | |||||||
| 120499492 | 12049949 | 14 | C | POTASSIUM CITRATE. | POTASSIUM CITRATE | 1 | 0 | 500 | MG | BID | |||||||||
| 120499492 | 12049949 | 15 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 120499492 | 12049949 | 16 | C | DIOVAN | VALSARTAN | 1 | 0 | ||||||||||||
| 120499492 | 12049949 | 17 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 120499492 | 12049949 | 18 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
| 120499492 | 12049949 | 19 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0 | 250 | UG | TABLET | QD | |||||||
| 120499492 | 12049949 | 20 | C | EXEMESTANE. | EXEMESTANE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 120499492 | 12049949 | 21 | C | CARAFATE | SUCRALFATE | 1 | Oral | 0 | 1 | G | TABLET | QD | |||||||
| 120499492 | 12049949 | 22 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 0 | 35 | MG | /wk | |||||||||
| 120499492 | 12049949 | 23 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 500 | MG | TABLET | BID | |||||||
| 120499492 | 12049949 | 24 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 0 | 100 | MG | CAPSULE | QD | |||||||
| 120499492 | 12049949 | 25 | C | NYSTATIN. | NYSTATIN | 1 | Oral | 0 | TABLET | ||||||||||
| 120499492 | 12049949 | 26 | C | AVAPRO | IRBESARTAN | 1 | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120499492 | 12049949 | 1 | Blood cholesterol increased |
| 120499492 | 12049949 | 2 | Blood cholesterol increased |
| 120499492 | 12049949 | 3 | Blood cholesterol increased |
| 120499492 | 12049949 | 4 | Gastric pH decreased |
| 120499492 | 12049949 | 10 | Gastric pH decreased |
| 120499492 | 12049949 | 15 | Gastric pH decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120499492 | 12049949 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120499492 | 12049949 | Diabetic neuropathy | |
| 120499492 | 12049949 | Fatigue | |
| 120499492 | 12049949 | Gastric pH decreased | |
| 120499492 | 12049949 | Type 2 diabetes mellitus | |
| 120499492 | 12049949 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120499492 | 12049949 | 1 | 20060126 | 0 | ||
| 120499492 | 12049949 | 2 | 20070301 | 0 | ||
| 120499492 | 12049949 | 3 | 20100802 | 0 | ||
| 120499492 | 12049949 | 4 | 2006 | 0 | ||
| 120499492 | 12049949 | 5 | 20070529 | 0 | ||
| 120499492 | 12049949 | 6 | 2006 | 0 | ||
| 120499492 | 12049949 | 7 | 20070125 | 0 | ||
| 120499492 | 12049949 | 9 | 2006 | 0 | ||
| 120499492 | 12049949 | 10 | 2006 | 0 | ||
| 120499492 | 12049949 | 11 | 2006 | 0 | ||
| 120499492 | 12049949 | 12 | 2006 | 0 | ||
| 120499492 | 12049949 | 13 | 201403 | 0 | ||
| 120499492 | 12049949 | 14 | 201403 | 0 | ||
| 120499492 | 12049949 | 15 | 2006 | 0 | ||
| 120499492 | 12049949 | 16 | 2006 | 0 | ||
| 120499492 | 12049949 | 17 | 2006 | 0 | ||
| 120499492 | 12049949 | 18 | 2006 | 0 | ||
| 120499492 | 12049949 | 19 | 2006 | 0 | ||
| 120499492 | 12049949 | 20 | 2006 | 0 | ||
| 120499492 | 12049949 | 21 | 2006 | 0 |